electroCore Stock (NASDAQ:ECOR)

Chart

Previous Close

$5.19

52W Range

$4.65 - $19.49

50D Avg

$8.54

200D Avg

$10.36

Market Cap

$34.51M

Avg Vol (3M)

$158.24K

Beta

0.92

Div Yield

ECOR Company Profile

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

Country

Employees

IPO Date

Jun 22, 2018

Website

ECOR Performance

Total Return %

YTD

10Y

ECOR

S&P 500

-10.40%

-31.72%

-15.76%

-72.71%

-65.53%

-72.27%

-32.02%

0.22%

-68.69%

-98.44%

-0.15%

0.30%

7.56%

-6.72%

-5.68%

-3.49%

8.33%

41.38%

92.90%

167.90%

Latest Earnings Call Transcripts

Q2 22Aug 07, 22 | 8:01 AM

Q1 22May 08, 22 | 10:36 PM

Q4 21Mar 10, 22 | 10:34 PM

Peer Comparison

Ticker	Company
SSKN	STRATA Skin Sciences, Inc.
IRIX	IRIDEX Corporation

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools